Medical Devices — Remaining performance obligations
Abbott Medical Devices — Remaining performance obligations decreased by 3.4% to $429.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.4%, from $423.00M to $429.00M. Over 3 years (FY 2022 to FY 2025), Medical Devices — Remaining performance obligations shows relatively stable performance with a 0.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests a growing backlog of future business, while a decrease may indicate a slowdown in new contract signings or faster fulfillment.
Detailed definition
Represents the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied or pa...
Peer comparison
Common in companies with service-heavy or long-term contract-based medical device business models.
abt_segment_medical_devices_remaining_performance_obligationsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $414.00M | $445.00M | $435.00M | $428.00M | $436.00M | $433.00M | $432.00M | $450.00M | $475.00M | $456.00M | $478.00M | $495.00M | $493.00M | $466.00M | $440.00M | $423.00M | $427.00M | $436.00M | $444.00M | $429.00M |
| QoQ Change | — | +7.5% | -2.2% | -1.6% | +1.9% | -0.7% | -0.2% | +4.2% | +5.6% | -4.0% | +4.8% | +3.6% | -0.4% | -5.5% | -5.6% | -3.9% | +0.9% | +2.1% | +1.8% | -3.4% |
| YoY Change | — | — | — | — | +5.3% | -2.7% | -0.7% | +5.1% | +8.9% | +5.3% | +10.6% | +10.0% | +3.8% | +2.2% | -7.9% | -14.5% | -13.4% | -6.4% | +0.9% | +1.4% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Abbott's medical devices — remaining performance obligations?
- Abbott (ABT) reported medical devices — remaining performance obligations of $429.00M in Q1 2026.
- How has Abbott's medical devices — remaining performance obligations changed year-over-year?
- Abbott's medical devices — remaining performance obligations increased by 1.4% year-over-year, from $423.00M to $429.00M.
- What is the long-term trend for Abbott's medical devices — remaining performance obligations?
- Over 3 years (2022 to 2025), Abbott's medical devices — remaining performance obligations has grown at a 0.0% compound annual growth rate (CAGR), from $1.73B to $1.73B.
- What does medical devices — remaining performance obligations mean?
- The total value of contracted work that has not yet been delivered or recognized as revenue.